Introduction
This report provides a comprehensive analytics report of the publisher Bentham Science Publishers Ltd. including basic bibliometric information, citation data, impact metrics, top journals, publication keywords, etc., over recent years. The Crossref database (up to the end of 2021) processed by ScienceGate has been used for this report as the source of data.
Bentham Science Publishers Ltd. has published 155335 documents so far, receiving a total of 1421042 citations. These numbers are equal to 0.13% and 0.13% of the total documents and citations in the scientific community, respectively. Bentham Science Publishers Ltd. has a score of 9.15 as a number of citations per document based on all recorded data. There are different types of documents published by Bentham Science Publishers Ltd.. In this regard, Journal Article, Chapter, Other, Book, and Monograph a with the total document number of 139848, 14377, 47, 990, and 73 have the largest share, respectively. These numbers are equal to 90.03%, 9.26%, 0.03%, 0.64%, and 0.05% of the total documents published in Bentham Science Publishers Ltd. so far, respectively. Bentham Science Publishers Ltd. has been an active publisher from 1969-2021.
Basic Bibliometric Information
This section provides the bibliometrics data of Bentham Science Publishers Ltd. over the last 11 years, including the number of published documents, total citations, citations per document, and scaled number of citations per document by year. Share of Bentham Science Publishers Ltd. documents and citations among all published scientific documents are also presented here. Bentham Science Publishers Ltd. has the highest annual number of publications in 2020, with 15380 published documents. Most annual citations are also received in 2010, with 112533 citations. The highest citations per document’s scores, scaled by the number of years ahead, are associated with 2020, with scores of 0.41.
Year | Documents | Citations | Citations/Documents | Average Citations/Documents | Documents Share | Citations Share |
---|---|---|---|---|---|---|
2010 | 8195 | 112533 | 13.7319 | 1.2484 | 0.0023 | 0.0027 |
2011 | 8426 | 114162 | 13.5488 | 1.3549 | 0.0022 | 0.0028 |
2012 | 14615 | 114301 | 7.8208 | 0.8690 | 0.0036 | 0.0029 |
2013 | 10313 | 84913 | 8.2336 | 1.0292 | 0.0024 | 0.0022 |
2014 | 8988 | 67997 | 7.5653 | 1.0808 | 0.0019 | 0.0019 |
2015 | 11176 | 59810 | 5.3516 | 0.8919 | 0.0023 | 0.0019 |
2016 | 9305 | 46150 | 4.9597 | 0.9919 | 0.0018 | 0.0017 |
2017 | 8818 | 33285 | 3.7747 | 0.9437 | 0.0016 | 0.0015 |
2018 | 9595 | 29548 | 3.0795 | 1.0265 | 0.0016 | 0.0017 |
2019 | 8946 | 17243 | 1.9275 | 0.9637 | 0.0014 | 0.0018 |
2020 | 15380 | 6238 | 0.4056 | 0.4056 | 0.0022 | 0.0018 |
Document Types
There are different types of documents published by publishers. In this section, the yearly publication data of Bentham Science Publishers Ltd. are presented by document type, including Journal Articles, Chapters, Books, and Monographs.
The number of published documents by Bentham Science Publishers Ltd. are 139848, 14377, 990, and 73 for Journal Articles, Chapters, Books, and Monographs, respectively. These numbers are equal to 0.15%, 0.09%, 0.11%, and 0.01% of the whole published Journal Articles, Chapters, Books, and Monographs in the database so far, respectively.
The number of received citations by Journal Articles, Chapters, Books, and Monographs of Bentham Science Publishers Ltd. are 1417889, 2216, 925, and 9, respectively. These numbers are equal to 0.13%, 0.01%, 0.01%, and 0.00% of the citations received by whole Journal Articles, Chapters, Books, and Monographs of the database so far, respectively.
The h-index value for published Journal Articles, Chapters, Books, and Monographs by Bentham Science Publishers Ltd. are 237, 12, 12, and 2, respectively. The corresponding values for the whole data of the database are 3201, 588, 793, and 760, respectively.
The g-index value for published Journal Articles, Chapters, Books, and Monographs by Bentham Science Publishers Ltd. are 24, 5, 5, and 2, respectively. The corresponding values for the whole data of the database are 129, 48, 60, and 60, respectively.
The score of citations per document for published Journal Articles, Chapters, Books, and Monographs by Bentham Science Publishers Ltd. are 10.139, 0.154, 0.934, and 0.123, respectively. The corresponding values for the whole data of the database are 11.521, 1.016, 8.593, and 9.566, respectively.
The highest number of annually published Journal Articles, Chapters, Books, and Monographs by Bentham Science Publishers Ltd. are 14139, 4646, 291, and 21, respectively. The corresponding year of maximum publication for Journal Articles, Chapters, Books, and Monographs are 2020, 2012, 2012, and 2020, respectively.
The highest number of annual received citations by Journal Articles, Chapters, Books, and Monographs published in Bentham Science Publishers Ltd. are 114100, 955, 549, and 3, respectively. The corresponding years of maximum received citations for Journal Articles, Chapters, Books, and Monographs are 2011, 2012, 2012, and 2018, respectively.
The highest values of citations per number of document for Journal Articles, Chapters, Books, and Monographs published in Bentham Science Publishers Ltd. are 13.89, 0.29, 1.89, and 1.50, respectively. The corresponding years of maximum values of citations per document for Journal Articles, Chapters, Books, and Monographs are 2011, 2011, 2012, and 2018, respectively.
Impact Metrics
Various metrics and indicators are used to evaluate the impact and quality of publishers and journals. Here, h-index, g-index, and i-index are selected as impact evaluation metrics of the publisher Bentham Science Publishers Ltd..
H-index
H-index indicates the number of articles published by a journal/publisher, h, that have been cited at least h times. h5-index and h10-index are the h-index for papers of a publishers/journals published in the last 5 and 10 years, respectively. h-index, h10-index, and h5-index of the documents published by Bentham Science Publishers Ltd., are 237, 142, and 66, respectively. The corresponding values for the whole data of the database are 3269, 1489, and 795, respectively.
Metric | Bentham Science Publishers Ltd. | All Publishers |
---|---|---|
h-index | 237 | 3269 |
h10-index | 142 | 1489 |
h5-index | 66 | 795 |
G-index
The g-index indicator is the first g papers of a publisher/journal (sorted by the highest to the lowest number of citations) that have cumulatively received at least g^2 citations. Again, g5-index and g10-index are the g-index for papers of a publishers/journals published in the last 5 and 10 years, respectively. G-index, g10-index, and g5-index of the documents published by Bentham Science Publishers Ltd. are 24, 19, and 11, respectively. The corresponding values for the whole data of the database are 131, 80, and 55, respectively.
Metric | Bentham Science Publishers Ltd. | All Publishers |
---|---|---|
g-index | 24 | 131 |
g10-index | 19 | 80 |
g5-index | 11 | 55 |
I-n index
I-n index shows the number of publications of a publisher/journal with at least n citations. Read another post here for more detailed information on different research impact metrics. It is to be noted that, i10-index, i25-index, i50-index, i100-index, i250-index, i500-index, i1000-index, i2500-index, i5000-index, and i10000-index of the documents published by Bentham Science Publishers Ltd., are 35130, 15580, 6152, 1776, 211, 27, 3, 1, 0, and 0, respectively. The corresponding values for the whole data of the database are 21796896, 10617845, 4822066, 1785083, 390499, 114230, 31648, 5505, 1423, and 355, respectively.
Metric | Bentham Science Publishers Ltd. | All Publishers |
---|---|---|
i10-index | 35130 | 21796896 |
i25-index | 15580 | 10617845 |
i50-index | 6152 | 4822066 |
i100-index | 1776 | 1785083 |
i250-index | 211 | 390499 |
i500-index | 27 | 114230 |
i1000-index | 3 | 31648 |
i2500-index | 1 | 5505 |
i5000-index | 0 | 1423 |
i10000-index | 0 | 355 |
Top Journals
This section provides the basic bibliometrics data of the Bentham Science Publishers Ltd. top journals, including the number of published documents, total citations, and citations per document. Share of documents and citations of each journal among all published documents by Bentham Science Publishers Ltd. is also presented here. In the following tag cloud chart, top journals are displayed based on the largest number of published documents.
The Top 5 journals of Bentham Science Publishers Ltd. based on the number of published documents are Current Pharmaceutical Design, Current Medicinal Chemistry, Current Topics in Medicinal Chemistry, Current Organic Chemistry, and Protein and Peptide Letters. The numbers of documents published so far by these top 5 journals are 9595, 6890, 4117, 3264, and 3118, respectively. These numbers are equal to 6.177%, 4.436%, 2.650%, 2.101%, and 2.007% of the total documents published by Bentham Science Publishers Ltd. so far, respectively.
Concerning the number of received citations, the top 5 journals of Bentham Science Publishers Ltd. are Current Pharmaceutical Design, Current Medicinal Chemistry, Current Topics in Medicinal Chemistry, Current Drug Targets, and Current Organic Chemistry. The total number of citations received so far by these top 5 journals are 9595, 6890, 4117, 3010, and 3264, respectively. These numbers are equal to 0.675%, 0.485%, 0.290%, 0.212%, and 0.230% of the total citations received by Bentham Science Publishers Ltd. publications so far, respectively.
Regarding the number of citations received per document, the top 5 journals of Bentham Science Publishers Ltd. are Current Medicinal Chemistry, Current Drug Metabolism, Current Molecular Medicine, Current Cancer Drug Targets, and Current Pharmaceutical Design. The numbers of citations received per published document so far by these top 5 journals are 25.820, 23.411, 22.698, 21.556, and 18.853, respectively.
Journal Title | Documents | Documents Share | Citations | Citations Share | Citations/Documents | Active Years |
---|---|---|---|---|---|---|
Current Pharmaceutical Design | 9595 | 0.0618 | 180891 | 0.1273 | 18.8526 | 2000-2020 |
Current Medicinal Chemistry | 6890 | 0.0444 | 177899 | 0.1252 | 25.8199 | 1970-2020 |
Current Topics in Medicinal Chemistry | 4117 | 0.0265 | 76967 | 0.0542 | 18.6949 | 2001-2020 |
Current Organic Chemistry | 3264 | 0.0210 | 51588 | 0.0363 | 15.8051 | 2000-2020 |
Protein and Peptide Letters | 3118 | 0.0201 | 21322 | 0.0150 | 6.8384 | 2001-2020 |
Current Drug Targets | 3010 | 0.0194 | 55539 | 0.0391 | 18.4515 | 2000-2020 |
Mini-Reviews in Medicinal Chemistry | 2802 | 0.0180 | 42775 | 0.0301 | 15.2659 | 2001-2020 |
Anti-Cancer Agents in Medicinal Chemistry | 2630 | 0.0169 | 27624 | 0.0194 | 10.5034 | 2002-2020 |
Current Pharmaceutical Biotechnology | 2624 | 0.0169 | 34084 | 0.0240 | 12.9893 | 2000-2020 |
Letters in Organic Chemistry | 2612 | 0.0168 | 9819 | 0.0069 | 3.7592 | 2004-2020 |
Letters in Drug Design & Discovery | 2357 | 0.0152 | 7045 | 0.0050 | 2.9890 | 2004-2020 |
Combinatorial Chemistry & High Throughput Screening | 2312 | 0.0149 | 19471 | 0.0137 | 8.4217 | 1969-2020 |
Current Molecular Medicine | 1966 | 0.0127 | 44625 | 0.0314 | 22.6984 | 2001-2020 |
Current Alzheimer Research | 1922 | 0.0124 | 35125 | 0.0247 | 18.2752 | 1970-2020 |
Current Drug Metabolism | 1901 | 0.0122 | 44504 | 0.0313 | 23.4108 | 2000-2020 |
CNS & Neurological Disorders – Drug Targets | 1747 | 0.0112 | 23473 | 0.0165 | 13.4362 | 2006-2020 |
Current Nanoscience | 1622 | 0.0104 | 10745 | 0.0076 | 6.6245 | 2005-2020 |
Medicinal Chemistry | 1619 | 0.0104 | 10324 | 0.0073 | 6.3768 | 2005-2020 |
Current Protein and Peptide Science | 1618 | 0.0104 | 28383 | 0.0200 | 17.5420 | 2000-2020 |
Current Drug Delivery | 1517 | 0.0098 | 15650 | 0.0110 | 10.3164 | 2004-2020 |
Current Cancer Drug Targets | 1516 | 0.0098 | 32679 | 0.0230 | 21.5561 | 2001-2020 |
Current Vascular Pharmacology | 1403 | 0.0090 | 16556 | 0.0117 | 11.8004 | 2003-2020 |
Current Neuropharmacology | 1390 | 0.0089 | 25334 | 0.0178 | 18.2259 | 2003-2020 |
Current Genomics | 1220 | 0.0079 | 18542 | 0.0130 | 15.1984 | 2000-2020 |
Endocrine Metabolic & Immune Disorders – Drug Targets | 1209 | 0.0078 | 7551 | 0.0053 | 6.2457 | 2006-2020 |
Current Medical Imaging Formerly Current Medical Imaging Reviews | 1200 | 0.0077 | 3769 | 0.0027 | 3.1408 | 2005-2020 |
Current HIV Research | 1196 | 0.0077 | 13158 | 0.0093 | 11.0017 | 2003-2020 |
Current Analytical Chemistry | 1134 | 0.0073 | 5578 | 0.0039 | 4.9189 | 2005-2020 |
Current Organic Synthesis | 1041 | 0.0067 | 9499 | 0.0067 | 9.1249 | 2004-2020 |
Current Bioinformatics | 1041 | 0.0067 | 4064 | 0.0029 | 3.9039 | 2006-2020 |
Current Pharmaceutical Analysis | 1031 | 0.0066 | 3015 | 0.0021 | 2.9243 | 2005-2020 |
Current Diabetes Reviews | 1028 | 0.0066 | 12907 | 0.0091 | 12.5554 | 2005-2020 |
Current Stem Cell Research & Therapy | 1017 | 0.0065 | 10769 | 0.0076 | 10.5890 | 2006-2020 |
Current Nutrition & Food Science | 996 | 0.0064 | 2930 | 0.0021 | 2.9418 | 2005-2020 |
Current Gene Therapy | 984 | 0.0063 | 18213 | 0.0128 | 18.5091 | 2001-2020 |
The Open Orthopaedics Journal | 971 | 0.0063 | 7345 | 0.0052 | 7.5644 | 2007-2020 |
The Open Dentistry Journal | 939 | 0.0060 | 4152 | 0.0029 | 4.4217 | 2007-2020 |
Current Bioactive Compounds | 935 | 0.0060 | 2910 | 0.0020 | 3.1123 | 2005-2020 |
Infectious Disorders – Drug Targets | 867 | 0.0056 | 6160 | 0.0043 | 7.1050 | 2006-2020 |
Mini-Reviews in Organic Chemistry | 857 | 0.0055 | 6373 | 0.0045 | 7.4364 | 2004-2020 |
Current Neurovascular Research | 846 | 0.0054 | 10137 | 0.0071 | 11.9823 | 2004-2020 |
The Open Cybernetics & Systemics Journal | 833 | 0.0054 | 655 | 0.0005 | 0.7863 | 2007-2018 |
Current Respiratory Medicine Reviews | 813 | 0.0052 | 960 | 0.0007 | 1.1808 | 2005-2020 |
Current Cardiology Reviews | 813 | 0.0052 | 8026 | 0.0056 | 9.8721 | 2005-2020 |
Current Drug Safety | 767 | 0.0049 | 5943 | 0.0042 | 7.7484 | 2006-2020 |
The Open Automation and Control Systems Journal | 729 | 0.0047 | 425 | 0.0003 | 0.5830 | 2008-2018 |
Current Rheumatology Reviews | 728 | 0.0047 | 2392 | 0.0017 | 3.2857 | 2005-2020 |
Current Pediatric Reviews | 704 | 0.0045 | 2058 | 0.0014 | 2.9233 | 2005-2020 |
Current Women s Health Reviews | 695 | 0.0045 | 958 | 0.0007 | 1.3784 | 2005-2020 |
Current Computer – Aided Drug Design | 688 | 0.0044 | 4427 | 0.0031 | 6.4346 | 2005-2020 |
Current Drug Discovery Technologies | 683 | 0.0044 | 6267 | 0.0044 | 9.1757 | 2004-2020 |
Current Proteomics | 662 | 0.0043 | 2251 | 0.0016 | 3.4003 | 2004-2020 |
The Open Civil Engineering Journal | 661 | 0.0043 | 1202 | 0.0008 | 1.8185 | 2007-2020 |
Reviews on Recent Clinical Trials | 658 | 0.0042 | 3882 | 0.0027 | 5.8997 | 2006-2020 |
Recent Patents on Engineering | 601 | 0.0039 | 1916 | 0.0013 | 3.1880 | 2007-2020 |
Current Clinical Pharmacology | 585 | 0.0038 | 5748 | 0.0040 | 9.8256 | 2006-2020 |
Current Hypertension Reviews | 581 | 0.0037 | 2004 | 0.0014 | 3.4492 | 2005-2020 |
Recent Patents on Anti-Cancer Drug Discovery | 577 | 0.0037 | 5779 | 0.0041 | 10.0156 | 2006-2020 |
Current Cancer Therapy Reviews | 562 | 0.0036 | 1021 | 0.0007 | 1.8167 | 2005-2020 |
The Natural Products Journal | 551 | 0.0035 | 300 | 0.0002 | 0.5445 | 2011-2020 |
Current Molecular Pharmacology | 539 | 0.0035 | 5351 | 0.0038 | 9.9276 | 2008-2020 |
Recent Patents on Mechanical Engineering | 536 | 0.0035 | 742 | 0.0005 | 1.3843 | 2008-2020 |
The Open Mechanical Engineering Journal | 509 | 0.0033 | 772 | 0.0005 | 1.5167 | 2007-2020 |
Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) | 508 | 0.0033 | 69 | 0.0000 | 0.1358 | 2014-2020 |
The Open Construction and Building Technology Journal | 503 | 0.0032 | 1532 | 0.0011 | 3.0457 | 2007-2020 |
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry | 502 | 0.0032 | 1648 | 0.0012 | 3.2829 | 1970-2020 |
Current Psychiatry Reviews | 498 | 0.0032 | 3365 | 0.0024 | 6.7570 | 2005-2019 |
Recent Patents on Computer Science | 497 | 0.0032 | 842 | 0.0006 | 1.6942 | 2008-2019 |
Cardiovascular & Haematological Disorders – Drug Targets | 488 | 0.0031 | 3713 | 0.0026 | 7.6086 | 2006-2020 |
Clinical Practice and Epidemiology in Mental Health | 487 | 0.0031 | 6818 | 0.0048 | 14.0000 | 2005-2020 |
Current Radiopharmaceuticals | 486 | 0.0031 | 2665 | 0.0019 | 5.4835 | 2008-2020 |
Recent Advances in Computer Science and Communications | 486 | 0.0031 | 55 | 0.0000 | 0.1132 | 2018-2020 |
The Open Conference Proceedings Journal | 478 | 0.0031 | 552 | 0.0004 | 1.1548 | 2010-2018 |
Current Signal Transduction Therapy | 476 | 0.0031 | 1194 | 0.0008 | 2.5084 | 2006-2020 |
Current Drug Therapy | 471 | 0.0030 | 1207 | 0.0008 | 2.5626 | 2006-2020 |
Micro and Nanosystems | 469 | 0.0030 | 951 | 0.0007 | 2.0277 | 2009-2020 |
International Journal of Sensors Wireless Communications and Control | 465 | 0.0030 | 209 | 0.0001 | 0.4495 | 2011-2020 |
Recent Patents on Nanotechnology | 462 | 0.0030 | 2902 | 0.0020 | 6.2814 | 2007-2020 |
Cardiovascular & Hematological Agents in Medicinal Chemistry | 454 | 0.0029 | 3935 | 0.0028 | 8.6674 | 2006-2020 |
Current Aging Science | 452 | 0.0029 | 4011 | 0.0028 | 8.8739 | 2008-2020 |
Drug Metabolism Letters | 449 | 0.0029 | 2816 | 0.0020 | 6.2717 | 2007-2020 |
Vascular Disease Prevention | 447 | 0.0029 | 359 | 0.0003 | 0.8031 | 2004-2010 |
Central Nervous System Agents in Medicinal Chemistry | 445 | 0.0029 | 3443 | 0.0024 | 7.7371 | 2006-2020 |
Recent Patents on Biotechnology | 440 | 0.0028 | 3491 | 0.0025 | 7.9341 | 2007-2020 |
Current Immunology Reviews | 439 | 0.0028 | 1994 | 0.0014 | 4.5421 | 2005-2020 |
Inflammation & Allergy – Drug Targets | 437 | 0.0028 | 8221 | 0.0058 | 18.8124 | 2006-2016 |
The Open Public Health Journal | 432 | 0.0028 | 379 | 0.0003 | 0.8773 | 2008-2020 |
Current Biotechnology | 419 | 0.0027 | 1020 | 0.0007 | 2.4344 | 2012-2020 |
Nanoscience &Nanotechnology-Asia | 415 | 0.0027 | 363 | 0.0003 | 0.8747 | 2011-2020 |
Current Enzyme Inhibition | 410 | 0.0026 | 1130 | 0.0008 | 2.7561 | 2005-2020 |
The Open Microbiology Journal | 400 | 0.0026 | 3629 | 0.0026 | 9.0725 | 2007-2020 |
Adolescent Psychiatry | 392 | 0.0025 | 480 | 0.0003 | 1.2245 | 2010-2020 |
The Open Ophthalmology Journal | 389 | 0.0025 | 2169 | 0.0015 | 5.5758 | 2007-2020 |
Current Physical Chemistry | 387 | 0.0025 | 775 | 0.0005 | 2.0026 | 2011-2020 |
Recent Patents on Anti-Infective Drug Discovery | 385 | 0.0025 | 3389 | 0.0024 | 8.8026 | 2006-2020 |
Recent Patents on Drug Delivery & Formulation | 385 | 0.0025 | 3455 | 0.0024 | 8.9740 | 2007-2020 |
Immunology Endocrine & Metabolic Agents – Medicinal Chemistry | 379 | 0.0024 | 946 | 0.0007 | 2.4960 | 2006-2018 |
Recent Patents on Inflammation & Allergy Drug Discovery | 375 | 0.0024 | 2789 | 0.0020 | 7.4373 | 1969-2020 |
Current Chemical Biology | 375 | 0.0024 | 717 | 0.0005 | 1.9120 | 2007-2020 |
Current Pharmacogenomics and Personalized Medicine | 357 | 0.0023 | 1086 | 0.0008 | 3.0420 | 2008-2020 |
Top Keywords
The Most used keywords are of particular importance for reviewing a publisher. This section provides detailed information about basic bibliometrics data of top used keywords in Bentham Science Publishers Ltd.. The metrics used here are the number of documents, citations and citations per document. Share of documents and citations of each keyword among whole published documents is also presented here. In the following tag cloud chart, top keywords are displayed based on the largest number of published documents.
According to the number of published documents, the top 10 keywords of the publisher Bentham Science Publishers Ltd. are in vitro, board member, drug delivery, drug discovery, oxidative stress, recent advances, breast cancer, stem cells, alzheimer’s disease, and alzheimer’s disease, respectively. The number of published documents in which the mentioned 10 keywords are used are, 3325, 2447, 2093, 1467, 1445, 1394, 1381, 1361, 1353, and 1331, respectively.
Based on the number of received citations, the top 10 keywords of the publisher Bentham Science Publishers Ltd. are oxidative stress, drug discovery, drug delivery, alzheimers disease, recent advances, cancer therapy, in vitro, stem cells, alzheimer’s disease, and alzheimer’s disease, respectively. The number of citations received by the documents in which the mentioned 10 keywords are used are, 1445, 1467, 2093, 599, 1394, 998, 3325, 1361, 1353, and 1331, respectively.
Concerning the score of received citations per document, the top 10 keywords of the publisher Bentham Science Publishers Ltd. are alzheimers disease, therapeutic target, recent developments, oxidative stress, medicinal chemistry, cancer therapy, therapeutic targets, therapeutic potential, anti cancer, and anticancer agents, respectively. The score of citations received per document in which the mentioned 10 keywords are used are, 36.154, 19.953, 19.141, 18.616, 17.783, 17.252, 16.744, 16.703, 16.236, and 16.198, respectively.
Keyword | Documents | Documents Share | Citations | Citations Share | Citations/Documents | Active Years | Active Years For All Data |
---|---|---|---|---|---|---|---|
in vitro | 3325 | 0.0065 | 16190 | 0.0019 | 4.8692 | 2000-2020 | 1500-2020 |
board member | 2447 | 0.6807 | 205 | 0.1494 | 0.0838 | 2010-2020 | 1916-2020 |
drug delivery | 2093 | 0.0422 | 21719 | 0.0197 | 10.3770 | 2000-2020 | 1969-2020 |
drug discovery | 1467 | 0.0775 | 21776 | 0.0601 | 14.8439 | 1970-2020 | 1964-2020 |
oxidative stress | 1445 | 0.0142 | 26900 | 0.0126 | 18.6159 | 2000-2020 | 1955-2020 |
recent advances | 1394 | 0.0277 | 19525 | 0.0188 | 14.0065 | 2000-2020 | 1848-2020 |
breast cancer | 1381 | 0.0047 | 9128 | 0.0021 | 6.6097 | 2000-2020 | 1880-2020 |
stem cells | 1361 | 0.0106 | 13920 | 0.0047 | 10.2278 | 2002-2020 | 1916-2020 |
alzheimer’s disease | 1353 | 0.0154 | 12775 | 0.0064 | 9.4420 | 2000-2020 | 1905-2020 |
alzheimer’s disease | 1331 | 0.0152 | 12698 | 0.0064 | 9.5402 | 2000-2020 | 1905-2020 |
guest editor | 1324 | 0.3217 | 1149 | 0.2536 | 0.8678 | 2000-2020 | 1957-2020 |
the world | 1177 | 0.0039 | 2035 | 0.0016 | 1.7290 | 2006-2020 | 1400-2020 |
clinical trials | 1169 | 0.0155 | 6522 | 0.0060 | 5.5791 | 2002-2020 | 1912-2020 |
diabetes mellitus | 1098 | 0.0087 | 7407 | 0.0050 | 6.7459 | 2001-2020 | 1811-2020 |
anti inflammatory | 1016 | 0.0191 | 12054 | 0.0144 | 11.8642 | 2000-2020 | 1923-2020 |
cancer therapy | 998 | 0.0450 | 17217 | 0.0346 | 17.2515 | 2000-2020 | 1924-2020 |
systematic review | 992 | 0.0047 | 8352 | 0.0023 | 8.4194 | 2005-2020 | 1846-2020 |
thematic issue | 964 | 0.6014 | 1193 | 0.5230 | 1.2376 | 2012-2020 | 1970-2020 |
natural products | 962 | 0.0509 | 9360 | 0.0304 | 9.7297 | 2000-2020 | 1819-2020 |
side effects | 914 | 0.0215 | 3903 | 0.0092 | 4.2702 | 2000-2020 | 1892-2020 |
in silico | 912 | 0.0333 | 4124 | 0.0226 | 4.5219 | 2001-2020 | 1897-2020 |
risk factors | 890 | 0.0043 | 4085 | 0.0015 | 4.5899 | 2003-2020 | 1948-2020 |
the future | 881 | 0.0037 | 2888 | 0.0024 | 3.2781 | 2000-2020 | 1676-2020 |
type 2 diabetes | 869 | 0.0083 | 8263 | 0.0047 | 9.5086 | 2001-2020 | 1905-2020 |
cancer cells | 866 | 0.0092 | 6518 | 0.0041 | 7.5266 | 2001-2020 | 1852-2020 |
hiv 1 | 860 | 0.0150 | 10502 | 0.0067 | 12.2116 | 2000-2020 | 1987-2020 |
nervous system | 858 | 0.0089 | 8326 | 0.0044 | 9.7040 | 2000-2020 | 1750-2020 |
type 2 | 858 | 0.0060 | 8753 | 0.0037 | 10.2016 | 2001-2020 | 1905-2020 |
molecular docking | 843 | 0.0565 | 2852 | 0.0351 | 3.3832 | 2007-2020 | 1970-2020 |
the impact | 794 | 0.0018 | 3557 | 0.0010 | 4.4798 | 2000-2020 | 1868-2020 |
gene expression | 792 | 0.0043 | 4885 | 0.0012 | 6.1679 | 2000-2020 | 1900-2020 |
the brain | 790 | 0.0079 | 5779 | 0.0033 | 7.3152 | 2001-2020 | 1666-2020 |
cell lines | 785 | 0.0105 | 2529 | 0.0020 | 3.2217 | 2004-2020 | 1934-2020 |
stem cell | 774 | 0.0066 | 5294 | 0.0026 | 6.8398 | 2001-2020 | 1929-2020 |
drug design | 765 | 0.1108 | 10730 | 0.0965 | 14.0261 | 2000-2020 | 1961-2020 |
cardiovascular disease | 743 | 0.0137 | 6973 | 0.0064 | 9.3849 | 2000-2020 | 1905-2020 |
anti cancer | 717 | 0.0684 | 11641 | 0.0847 | 16.2357 | 2000-2020 | 1912-2020 |
lung cancer | 678 | 0.0042 | 3445 | 0.0017 | 5.0811 | 2000-2020 | 1921-2020 |
central nervous system | 654 | 0.0113 | 6328 | 0.0052 | 9.6758 | 2000-2020 | 1843-2020 |
mass spectrometry | 636 | 0.0043 | 3550 | 0.0013 | 5.5818 | 2000-2020 | 1945-2020 |
medicinal chemistry | 636 | 0.1564 | 11310 | 0.1568 | 17.7830 | 2000-2020 | 1931-2020 |
the mean | 633 | 0.0043 | 1499 | 0.0010 | 2.3681 | 2004-2020 | 1669-2020 |
drug resistance | 632 | 0.0251 | 5145 | 0.0123 | 8.1408 | 2000-2020 | 1932-2020 |
growth factor | 613 | 0.0043 | 6964 | 0.0017 | 11.3605 | 2001-2020 | 1921-2020 |
cancer cell | 613 | 0.0140 | 2257 | 0.0033 | 3.6819 | 2000-2020 | 1905-2020 |
gene therapy | 612 | 0.0229 | 9573 | 0.0224 | 15.6422 | 2000-2020 | 1947-2020 |
nitric oxide | 605 | 0.0066 | 7808 | 0.0033 | 12.9058 | 2000-2020 | 1833-2020 |
alzheimers disease | 599 | 0.6413 | 21656 | 0.9204 | 36.1536 | 1970-2018 | 1970-2020 |
drug development | 593 | 0.0469 | 6446 | 0.0379 | 10.8702 | 2000-2020 | 1946-2020 |
heart failure | 580 | 0.0047 | 3823 | 0.0021 | 6.5914 | 2003-2020 | 1888-2020 |
delivery systems | 578 | 0.0435 | 6263 | 0.0249 | 10.8356 | 2001-2020 | 1900-2020 |
prostate cancer | 569 | 0.0043 | 4300 | 0.0023 | 7.5571 | 2001-2020 | 1905-2020 |
case report | 565 | 0.0019 | 1033 | 0.0012 | 1.8283 | 2002-2020 | 1904-2020 |
biological activity | 562 | 0.0221 | 4796 | 0.0135 | 8.5338 | 2000-2020 | 1925-2020 |
public health | 553 | 0.0041 | 1574 | 0.0019 | 2.8463 | 2005-2020 | 1835-2020 |
therapeutic target | 548 | 0.0414 | 10934 | 0.0460 | 19.9526 | 2000-2020 | 1977-2020 |
cancer treatment | 546 | 0.0260 | 5045 | 0.0199 | 9.2399 | 2002-2020 | 1850-2020 |
cell cycle | 543 | 0.0099 | 3307 | 0.0025 | 6.0902 | 2000-2020 | 1905-2020 |
quality of life | 540 | 0.0032 | 2007 | 0.0011 | 3.7167 | 2007-2020 | 1905-2020 |
rheumatoid arthritis | 516 | 0.0066 | 3405 | 0.0027 | 6.5988 | 2000-2020 | 1863-2020 |
amino acid | 516 | 0.0045 | 4557 | 0.0018 | 8.8314 | 2000-2020 | 1906-2020 |
wide range | 514 | 0.0067 | 1339 | 0.0016 | 2.6051 | 2000-2020 | 1858-2020 |
high throughput | 487 | 0.0103 | 5626 | 0.0064 | 11.5524 | 2000-2020 | 1955-2020 |
drug delivery systems | 486 | 0.0692 | 4559 | 0.0318 | 9.3807 | 2004-2020 | 1970-2020 |
cardiovascular diseases | 485 | 0.0283 | 3957 | 0.0236 | 8.1588 | 2002-2020 | 1913-2020 |
biological activities | 482 | 0.0417 | 6226 | 0.0383 | 12.9170 | 2000-2020 | 1919-2020 |
immune system | 475 | 0.0146 | 4364 | 0.0066 | 9.1874 | 2001-2020 | 1901-2020 |
cell line | 475 | 0.0076 | 1101 | 0.0010 | 2.3179 | 2000-2020 | 1923-2020 |
structure activity | 473 | 0.0236 | 6361 | 0.0169 | 13.4482 | 2000-2020 | 1952-2020 |
cell death | 472 | 0.0088 | 5141 | 0.0032 | 10.8919 | 2001-2020 | 1908-2020 |
blood pressure | 470 | 0.0041 | 1700 | 0.0011 | 3.6170 | 2003-2020 | 1874-2020 |
therapeutic targets | 469 | 0.0522 | 7853 | 0.0575 | 16.7441 | 2000-2020 | 1972-2020 |
small molecule | 463 | 0.0203 | 6851 | 0.0119 | 14.7970 | 2000-2020 | 1948-2020 |
machine learning | 460 | 0.0040 | 1875 | 0.0042 | 4.0761 | 2004-2020 | 1959-2020 |
recent developments | 460 | 0.0150 | 8805 | 0.0157 | 19.1413 | 1970-2020 | 1848-2020 |
metabolic syndrome | 457 | 0.0109 | 4404 | 0.0063 | 9.6368 | 2001-2020 | 1905-2020 |
drug targets | 452 | 0.1238 | 6105 | 0.0863 | 13.5066 | 2001-2020 | 1973-2020 |
neurodegenerative diseases | 451 | 0.0452 | 7207 | 0.0369 | 15.9800 | 2001-2020 | 1983-2020 |
therapeutic potential | 451 | 0.0493 | 7533 | 0.0449 | 16.7029 | 2001-2020 | 1955-2020 |
novel therapeutic | 450 | 0.0372 | 4286 | 0.0243 | 9.5244 | 2000-2020 | 1968-2020 |
animal models | 442 | 0.0168 | 3330 | 0.0071 | 7.5339 | 2001-2020 | 1920-2020 |
magnetic resonance | 439 | 0.0024 | 2568 | 0.0009 | 5.8497 | 2000-2020 | 1936-2020 |
significant difference | 438 | 0.0054 | 710 | 0.0019 | 1.6210 | 2007-2020 | 1923-2020 |
antimicrobial activity | 431 | 0.0163 | 1270 | 0.0038 | 2.9466 | 2002-2020 | 1944-2020 |
one pot | 431 | 0.0106 | 1331 | 0.0026 | 3.0882 | 2003-2020 | 1968-2020 |
antioxidant activity | 430 | 0.0140 | 1311 | 0.0030 | 3.0488 | 2006-2020 | 1930-2020 |
signaling pathways | 430 | 0.0170 | 3884 | 0.0065 | 9.0326 | 2002-2020 | 1969-2020 |
anticancer agents | 429 | 0.0779 | 6949 | 0.0717 | 16.1981 | 2001-2020 | 1951-2020 |
clinical practice | 428 | 0.0065 | 2897 | 0.0037 | 6.7687 | 2001-2020 | 1905-2020 |
amino acids | 427 | 0.0049 | 2896 | 0.0017 | 6.7822 | 2002-2020 | 1898-2020 |
meta analysis | 418 | 0.0024 | 2990 | 0.0008 | 7.1531 | 2005-2020 | 1953-2020 |